Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-02-17. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-03,-0.9,0.2,-1.6,5.0,5.0,-4.7,-6.5,-6.8,-6.6,-7.4,-8.2
2017-02-06,-0.2,0.2,-0.9,-0.6,-0.6,-2.7,-5.1,-5.9,-5.8,-6.4,-7.2
2017-02-07,0.1,0.5,-0.7,0.1,0.1,-1.7,-4.4,-5.5,-5.7,-6.0,-7.0
2017-02-08,-1.0,0.1,-1.1,0.8,0.8,-1.4,-4.3,-5.8,-6.2,-6.4,-7.3
2017-02-09,-1.0,0.2,-1.2,-0.4,-0.4,-0.1,-3.0,-4.8,-5.5,-5.7,-6.5
2017-02-10,-0.1,0.3,-0.5,0.3,0.3,-0.3,-2.6,-4.6,-5.3,-5.5,-6.4
2017-02-13,0.0,0.4,-0.6,-0.1,0.6,-0.6,-2.3,-4.4,-5.5,-5.8,-6.5
2017-02-14,-0.6,0.0,-1.5,0.2,0.2,-0.5,-1.8,-4.0,-5.3,-5.7,-6.2
2017-02-15,-2.6,0.1,-2.8,2.2,2.2,-2.1,-3.2,-5.3,-6.8,-7.5,-7.8
2017-02-16,-0.3,0.0,-1.1,0.2,0.2,-1.7,-2.6,-4.7,-6.4,-7.2,-7.6

2017-02-03: why morgan stanley, amgen, and tableau software jumped today $amgn $regn $ms $daya |sun life financial inc has $315,000 position in amgen inc. $amgn |rt AT_USER fourier love all around as repatha impr
2017-02-06: rt AT_USER the drug-pricing battle just opened up an interesting new front  $amgn #repatha via bloomberg AT_USER|the drug-pricing battle just opened up an interesting new front  $amgn #repatha via blo
2017-02-07: $atra $amgn bought 1.4 mill shares of $atra |brookmont capital management acquires 194 shares of amgen inc. $amgn |gargoyle investment advisor l.l.c. has $3,128,000 position in amgen inc. $amgn |gargo
2017-02-08: $amgn maturity 02/10/2017 vol putcallratio of 1.20 puts=1,272 calls=1,059 .  |rt AT_USER with history rooted in amgen, atara biotherapeutics coming to thousand oaks #atra $amgn |with history rooted in
2017-02-09: 5 things for #pharma #marketers to know: thurs., feb. 9 $sny $regn #pcsk9 $amgn $bayn AT_USER #trump #pbm $antm¡­ |why amgn was down thursday  $amgn|rt AT_USER us appeals court stays order blocking $s
2017-02-10: $amgn max pain is 155.00 for maturity 02/17/2017. prev close = 167.47.   |biotech etfs powered by q4 earnings $ibb $bbh $fbt also $amgn $vrtx $ilmn $celg $gild $biib |rt AT_USER aca, virtual reality, 
2017-02-11: rt AT_USER isi slide.  case to be made big cap biotech cheap here &amp; maybe even cheaper then big pharma ? $gild $celg $amgn $biib $regn¡­|$amgn high open interest range is 140.00 to 160.00 for opti
2017-02-12: rt AT_USER pharma m&amp;a in 2017: the most likely deal hunters  $amgn $gild $mrk $pfe|rt AT_USER pharma stocks getting clobbered.. great buying opportunity for the long term! $bmy $agn $abbv $pfe $mr
2017-02-13: rt AT_USER an examination of relative strength among biotech may provide a few trades. $regn $alxn $amgn $ilmn software available at AT_USER|rt AT_USER an examination of relative strength among biotec
2017-02-14: remarkable how well these names have performed since last month's tweet. $abt $amgn $bsx $cnc $esrx $ilmn $lly $rmd¡­ |amgen $amgn revenues boost 6% in 4q, driven by drug sales &amp; price hikes. yet,
2017-02-15: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|thursday: $shld, $juno, $amgn, $celg, $adi, $prgo, $gild, $cf, $fosl, $trip, $mnk, $bmy|all about the heart
2017-02-16: $amgn oi for maturity 02/17/2017. 155.00 highest put. 167.50 highest call.  |don't count on valeant's new drug to save the day $amgn $azn $vrx |AT_USER agree $amgn interesting, but  terms/clinical pro
Answer:
Examine the data and tweets to deduce if the closing price of $amgn will boost or lower at 2017-02-17. Kindly confirm either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-02-03,-0.9,0.2,-1.6,5.0,5.0,-4.7,-6.5,-6.8,-6.6,-7.4,-8.2
2017-02-06,-0.2,0.2,-0.9,-0.6,-0.6,-2.7,-5.1,-5.9,-5.8,-6.4,-7.2
2017-02-07,0.1,0.5,-0.7,0.1,0.1,-1.7,-4.4,-5.5,-5.7,-6.0,-7.0
2017-02-08,-1.0,0.1,-1.1,0.8,0.8,-1.4,-4.3,-5.8,-6.2,-6.4,-7.3
2017-02-09,-1.0,0.2,-1.2,-0.4,-0.4,-0.1,-3.0,-4.8,-5.5,-5.7,-6.5
2017-02-10,-0.1,0.3,-0.5,0.3,0.3,-0.3,-2.6,-4.6,-5.3,-5.5,-6.4
2017-02-13,0.0,0.4,-0.6,-0.1,0.6,-0.6,-2.3,-4.4,-5.5,-5.8,-6.5
2017-02-14,-0.6,0.0,-1.5,0.2,0.2,-0.5,-1.8,-4.0,-5.3,-5.7,-6.2
2017-02-15,-2.6,0.1,-2.8,2.2,2.2,-2.1,-3.2,-5.3,-6.8,-7.5,-7.8
2017-02-16,-0.3,0.0,-1.1,0.2,0.2,-1.7,-2.6,-4.7,-6.4,-7.2,-7.6

2017-02-03: why morgan stanley, amgen, and tableau software jumped today $amgn $regn $ms $daya |sun life financial inc has $315,000 position in amgen inc. $amgn |rt AT_USER fourier love all around as repatha impr
2017-02-06: rt AT_USER the drug-pricing battle just opened up an interesting new front  $amgn #repatha via bloomberg AT_USER|the drug-pricing battle just opened up an interesting new front  $amgn #repatha via blo
2017-02-07: $atra $amgn bought 1.4 mill shares of $atra |brookmont capital management acquires 194 shares of amgen inc. $amgn |gargoyle investment advisor l.l.c. has $3,128,000 position in amgen inc. $amgn |gargo
2017-02-08: $amgn maturity 02/10/2017 vol putcallratio of 1.20 puts=1,272 calls=1,059 .  |rt AT_USER with history rooted in amgen, atara biotherapeutics coming to thousand oaks #atra $amgn |with history rooted in
2017-02-09: 5 things for #pharma #marketers to know: thurs., feb. 9 $sny $regn #pcsk9 $amgn $bayn AT_USER #trump #pbm $antm¡­ |why amgn was down thursday  $amgn|rt AT_USER us appeals court stays order blocking $s
2017-02-10: $amgn max pain is 155.00 for maturity 02/17/2017. prev close = 167.47.   |biotech etfs powered by q4 earnings $ibb $bbh $fbt also $amgn $vrtx $ilmn $celg $gild $biib |rt AT_USER aca, virtual reality, 
2017-02-11: rt AT_USER isi slide.  case to be made big cap biotech cheap here &amp; maybe even cheaper then big pharma ? $gild $celg $amgn $biib $regn¡­|$amgn high open interest range is 140.00 to 160.00 for opti
2017-02-12: rt AT_USER pharma m&amp;a in 2017: the most likely deal hunters  $amgn $gild $mrk $pfe|rt AT_USER pharma stocks getting clobbered.. great buying opportunity for the long term! $bmy $agn $abbv $pfe $mr
2017-02-13: rt AT_USER an examination of relative strength among biotech may provide a few trades. $regn $alxn $amgn $ilmn software available at AT_USER|rt AT_USER an examination of relative strength among biotec
2017-02-14: remarkable how well these names have performed since last month's tweet. $abt $amgn $bsx $cnc $esrx $ilmn $lly $rmd¡­ |amgen $amgn revenues boost 6% in 4q, driven by drug sales &amp; price hikes. yet,
2017-02-15: interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|thursday: $shld, $juno, $amgn, $celg, $adi, $prgo, $gild, $cf, $fosl, $trip, $mnk, $bmy|all about the heart
2017-02-16: $amgn oi for maturity 02/17/2017. 155.00 highest put. 167.50 highest call.  |don't count on valeant's new drug to save the day $amgn $azn $vrx |AT_USER agree $amgn interesting, but  terms/clinical pro
Answer:+Rise